Literature DB >> 20009932

Pancreas transplantation in the United States: a review.

Angelika C Gruessner1, David E R Sutherland, Rainer W G Gruessner.   

Abstract

PURPOSE OF REVIEW: The goal of pancreas transplantation is to restore normoglycemia in patients with labile diabetes. The results of this procedure improved over the years, but, although pancreas transplantation is not considered experimental anymore, there is often reluctance to recommend this procedure because of the complexity, especially for solitary pancreas transplants. This article reviews the current status of pancreas transplantation. RECENT
FINDINGS: Many improvements have been made in the surgical techniques and immunosuppressive regimens. The overall rate of technical problems decreased, yet immunologic graft loss is still a problem in solitary pancreas transplants. Careful donor selection significantly decreased the risk of graft failure and therefore improved patient survival.
SUMMARY: With modern immunosuppressive protocols and careful donor selection, patient survival rates and pancreas transplant graft function can be further improved in all three pancreas transplant categories.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20009932     DOI: 10.1097/MOT.0b013e32833552d2

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  24 in total

Review 1.  Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center.

Authors:  Jeffrey Rogers; Alan C Farney; Samer Al-Geizawi; Samy S Iskandar; William Doares; Michael D Gautreaux; Lois Hart; Scott Kaczmorski; Amber Reeves-Daniel; Stephanie Winfrey; Mythili Ghanta; Patricia L Adams; Robert J Stratta
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 2.  2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR).

Authors:  Angelika C Gruessner
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 3.  Adipose tissue, hormones, and treatment of type 1 diabetes.

Authors:  Subhadra C Gunawardana
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 4.  [Small intestine, pancreas and islet cell transplantation].

Authors:  C Lackner; F Offner; H Nizze
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

5.  Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients.

Authors:  Ugo Boggi; Fabio Vistoli; Gabriella Amorese; Rosa Giannarelli; Alberto Coppelli; Rita Mariotti; Lorenzo Rondinini; Massimiliamo Barsotti; Alberto Piaggesi; Anna Tedeschi; Stefano Signori; Nelide De Lio; Margherita Occhipinti; Emanuela Mangione; Diego Cantarovich; Stefano Del Prato; Franco Mosca; Piero Marchetti
Journal:  Rev Diabet Stud       Date:  2011-08-10

6.  Recurrence of autoimmunity in pancreas transplant patients: research update.

Authors:  Alberto Pugliese; Helena K Reijonen; Jerry Nepom; George W Burke
Journal:  Diabetes Manag (Lond)       Date:  2011-03

7.  Glucose-Stimulated Insulin Response of Silicon Nanopore-Immunoprotected Islets under Convective Transport.

Authors:  Shang Song; Raymond Yeung; Jaehyun Park; Andrew M Posselt; Tejal A Desai; Qizhi Tang; Shuvo Roy
Journal:  ACS Biomater Sci Eng       Date:  2017-04-11

8.  The IKEM pancreas and islet transplant program as part of healthcare for type 1 diabetes patients: retrospective analysis of outcome from 1983 to 2010.

Authors:  Peter Girman; Frantisek Saudek
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 9.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

Review 10.  The role of kidney-pancreas transplantation in diabetic kidney disease.

Authors:  Alexander C Wiseman
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.